According to the GAO report:
"FDA officials told us that the current regulatory framework is sufficient to identify and act on safety concerns regarding foods with added dietary ingredients."
They are referring to the Dietary Supplement Health and Education Act of 1994 (DSHEA).7 The only deficiency, to the extent it exists, lies in the enforcement of the current law, in terms of ensuring good manufacturing practices and mandatory reporting of adverse events by supplement companies. If the FDA is already well-equipped with legislative authority to do its job, then what is Senator Durbin really trying to accomplish?
The only answer that makes sense is that the ultimate goal of Durbin's bill is to make sure every supplement is approved by the FDA before it is sold.
The hidden problem with this is that the FDA is heavily biased in favor of drugs, as the agency is primarily funded by the pharmaceutical industry. The FDA sees supplements as competition for drugs, so not many will be approved. Durbin's bill attempts to get supplements into the clutches of our completely dysfunctional drug approval regime, where they can be subjected to every possible legal obstacle that will keep them off store shelves. Less competition from supplements would also soften the impact of decreased revenues from expiring drug patents.
Tell your Senator to vote no on Senate bill S 1310, the Dietary Supplement Labeling Act.